You are here

Breakfast seminar; Clinical Trials - The Direct to Patient Model

Thursday, 15 February, 2018 - 07:30 to 09:30

Stockholm Science City Foundation and World Courier is pleased to invite you to an educational seminar highlighting The Direct to Patient Model, i.e. clinical trials in a home environment. During the seminar you will meet Christina Vinum from Klifo A/S, Chris Elston from the Medical Research Network, and Gunilla Andrew-Nielsen from the Medical Products Agency who will participate in the panel discussion after the presentations. Welcome to a great opportunity to learn more and ask questions about a patient-centered approach to clinical trials.

The Direct to Patient delivers increase of patient recruitment by 60 percent or more, reduced on-site visits for patients and maintained patient retention at 95 percent or more.

When: February 15, 2018
Time: 08:00 – 09:30, breakfast is served from 07:30
Where: H2 Health Hub, Hälsingegatan 45, Stockholm

  • Christina joined KLIFO in February 2011 and became Vice President Clinical Trial Supply in 2014. Christina has 18 years’ experience with clinical trial supplies. Presentation: “Practical issues in setting up studies with Direct to patient administration”
  • Chris is Business Development Executive at MRN, the Medical Research Network. Chris has over 20 years’ experience working in the pharmaceutical industry.
    Presentation; “Home Trial Support: Conducting Study Visits in the Home”
  • Gunilla is Head of Clinical Trials at MPA, Medical Products Agency. 
Join the discussion and please stay after the seminar for additional networking. This seminar is held in English.
 
The seminar is a collaboration with Stockholm Science City and Tools of Science.
 
For more information about the seminar, please contact: srydman@worldcourier.se.
 
The seminar is free of charge. However, we reserve the right to charge a no-show fee of SEK 200. If you need to cancel, please contact klara.gustafsson@ssci.se or use the link you recieved in the confimation e-mail. 
 
Registration is now closed.